Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03442101 · ClinicalTrials.gov registry record
Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study
A clinical trial of Psychosis, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- 156
- Enrollment target
- 1
- Study location
NCT03442101 is a study of Psychosis that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 156 participants, below the 174-participant average among 35 other Psychosis trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03442101, a study of Psychosis, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
Psychosis is a heterogeneous disorder and present treatment only works for a limited number of patients. In order to identify new therapeutic targets, this study will longitudinally characterize the underlying pathologies in those with poor treatment response using complimentary brain imaging modalities.
Conditions Studied
Interventions
- DRUG Patients with psychosis will be treated with known antipsychotic medication
Study Locations (1)
Alabama
- Sparks Center - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03442101
The ClinicalTrials.gov registry entry for NCT03442101 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 174-participant average among 35 other Psychosis trials with a reported enrollment target (10% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Psychosis appearing as the primary indexed condition, and to 1 intervention - of which Patients with psychosis will be treated with known antipsychotic medication is the first listed.
NCT03442101 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT03442101 about?
NCT03442101 is a clinical study titled "Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study". Psychosis is a heterogeneous disorder and present treatment only works for a limited number of patients. In order to identify new therapeutic targets, this study will longitudinally characterize the underlying pathologies in those with poor treatment response using complimentary brain imaging modali...
What is the current status of trial NCT03442101?
This trial is currently active not recruiting. The enrollment target is 156 participants. The study started on 2018-04-01. Estimated completion is 2026-12-31.
What conditions does trial NCT03442101 study?
This clinical trial studies the following conditions: Psychosis.
What interventions are being tested in trial NCT03442101?
The interventions under investigation include: Patients with psychosis will be treated with known antipsychotic medication (DRUG).
Who is sponsoring clinical trial NCT03442101?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03442101 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psychosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
RECRUITING · NA
-
Determining the Role of Social Reward Learning in Social Anhedonia
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
RECRUITING · NA
-
Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care
RECRUITING · NA
-
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.